Bruker (BRKR)
(Delayed Data from NSDQ)
$65.88 USD
-2.45 (-3.59%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $65.85 -0.03 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Price, Consensus and EPS Surprise
BRKR 65.88 -2.45(-3.59%)
Will BRKR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BRKR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BRKR
What's in Store for These 4 MedTech Stocks in Q2 Earnings?
Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Q2 Release
BRKR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Bruker (BRKR) Beat Estimates Again in Its Next Earnings Report?
Bruker (BRKR) Banks on End Market Growth Amid Macro Headwinds
Bruker (BRKR) Expands in NMR Spectrometry With New FMP Collab
Other News for BRKR
Bruker Larger Than S&P 500 Component Paycom Software
Bruker Announces Date and Time of Second Quarter 2024 Earnings Release and Webcast
Fidelity Mid-Cap Stock Fund Q2 2024 Review
Bruker Announces that Injunction Impacting NanoString?s CosMx Spatial Molecular Imager Products in Germany Has Been Suspended Effective Immediately
Bruker posts bond in Germany to suspend injunction hurting sales of CosMx SMI